Winteam Pharmaceutical Group Limited reported audited consolidated earnings results for the year ended December 31, 2012. For the period, the company reported turnover of HKD 1,268,143,000 against HKD 1,015,935,000 a year ago. Profit from operations was HKD 289,815,000 against HKD 102,144,000 a year ago. Profit before taxation was HK 265,984,000 against HKD 94,455,000 a year ago. Profit for the year attributable to equity shareholders of the company was HKD 207,134,000 or 11.61 cents per basic and diluted share against HKD 72,072,000 or 4.04 cents per basic and diluted share a year ago. The increase in sales was attributable to the successful expansion of product coverage in primary health care institutions, as well as the partnerships established with major chain pharmacy which has increased its coverage in OTC retail market, resulting in the satisfactory growth of core products. Net cash generated from operating activities was HKD 228,080,000 against net cash used in operating activities of HKD 54,689,000 a year ago.

The Board of Winteam Pharmaceutical Group Limited has resolved not to declare a final dividend for the year ended 31 December 2012 compared with final dividend of HK 5.00 cents per share for the same period a year ago.

Winteam Pharmaceutical Group Limited, Board Meeting, Mar 23, 2013. Agenda: To consider and approve the final results of the company and its subsidiaries for the year ended December 31, 2012; and to consider the payment of a final dividend, if any.